507 related articles for article (PubMed ID: 25713080)
21. Sulforaphane suppresses PRMT5/MEP50 function in epidermal squamous cell carcinoma leading to reduced tumor formation.
Saha K; Fisher ML; Adhikary G; Grun D; Eckert RL
Carcinogenesis; 2017 Aug; 38(8):827-836. PubMed ID: 28854561
[TBL] [Abstract][Full Text] [Related]
22. RioK1, a new interactor of protein arginine methyltransferase 5 (PRMT5), competes with pICln for binding and modulates PRMT5 complex composition and substrate specificity.
Guderian G; Peter C; Wiesner J; Sickmann A; Schulze-Osthoff K; Fischer U; Grimmler M
J Biol Chem; 2011 Jan; 286(3):1976-86. PubMed ID: 21081503
[TBL] [Abstract][Full Text] [Related]
23. Glutathionylation Decreases Methyltransferase Activity of PRMT5 and Inhibits Cell Proliferation.
Yi M; Ma Y; Chen Y; Liu C; Wang Q; Deng H
Mol Cell Proteomics; 2020 Nov; 19(11):1910-1920. PubMed ID: 32868396
[TBL] [Abstract][Full Text] [Related]
24. Sulforaphane inhibits PRMT5 and MEP50 function to suppress the mesothelioma cancer cell phenotype.
Ezeka G; Adhikary G; Kandasamy S; Friedberg JS; Eckert RL
Mol Carcinog; 2021 Jul; 60(7):429-439. PubMed ID: 33872411
[TBL] [Abstract][Full Text] [Related]
25. Characterization of the Kinetic Mechanism of Human Protein Arginine Methyltransferase 5.
Eddershaw AR; Stubbs CJ; Edwardes LV; Underwood E; Hamm GR; Davey PRJ; Clarkson PN; Syson K
Biochemistry; 2020 Dec; 59(50):4775-4786. PubMed ID: 33274632
[TBL] [Abstract][Full Text] [Related]
26. Histone H4 acetylation differentially modulates arginine methylation by an in Cis mechanism.
Feng Y; Wang J; Asher S; Hoang L; Guardiani C; Ivanov I; Zheng YG
J Biol Chem; 2011 Jun; 286(23):20323-34. PubMed ID: 21502321
[TBL] [Abstract][Full Text] [Related]
27. Discovery and Biological Characterization of PRMT5:MEP50 Protein-Protein Interaction Inhibitors.
Asberry AM; Cai X; Deng X; Santiago U; Liu S; Sims HS; Liang W; Xu X; Wan J; Jiang W; Camacho CJ; Dai M; Hu CD
J Med Chem; 2022 Oct; 65(20):13793-13812. PubMed ID: 36206451
[TBL] [Abstract][Full Text] [Related]
28. Transient Kinetics Define a Complete Kinetic Model for Protein Arginine Methyltransferase 1.
Hu H; Luo C; Zheng YG
J Biol Chem; 2016 Dec; 291(52):26722-26738. PubMed ID: 27834681
[TBL] [Abstract][Full Text] [Related]
29. PRMT5- mediated symmetric arginine dimethylation is attenuated by mutant huntingtin and is impaired in Huntington's disease (HD).
Ratovitski T; Arbez N; Stewart JC; Chighladze E; Ross CA
Cell Cycle; 2015; 14(11):1716-29. PubMed ID: 25927346
[TBL] [Abstract][Full Text] [Related]
30. Identification of a novel inhibitor of coactivator-associated arginine methyltransferase 1 (CARM1)-mediated methylation of histone H3 Arg-17.
Selvi BR; Batta K; Kishore AH; Mantelingu K; Varier RA; Balasubramanyam K; Pradhan SK; Dasgupta D; Sriram S; Agrawal S; Kundu TK
J Biol Chem; 2010 Mar; 285(10):7143-52. PubMed ID: 20022955
[TBL] [Abstract][Full Text] [Related]
31. OGG1 regulates the level of symmetric dimethylation of histone H4 arginine-3 by interacting with PRMT5.
Zhou X; Wang W; Du C; Yan F; Yang S; He K; Wang H; Zhao A
Mol Cell Probes; 2018 Apr; 38():19-24. PubMed ID: 29409673
[TBL] [Abstract][Full Text] [Related]
32. MEP50/PRMT5-mediated methylation activates GLI1 in Hedgehog signalling through inhibition of ubiquitination by the ITCH/NUMB complex.
Abe Y; Suzuki Y; Kawamura K; Tanaka N
Commun Biol; 2019; 2():23. PubMed ID: 30675521
[TBL] [Abstract][Full Text] [Related]
33. OXR1A, a Coactivator of PRMT5 Regulating Histone Arginine Methylation.
Yang M; Lin X; Segers F; Suganthan R; Hildrestrand GA; Rinholm JE; Aas PA; Sousa MML; Holm S; Bolstad N; Warren D; Berge RK; Johansen RF; Yndestad A; Kristiansen E; Klungland A; Luna L; Eide L; Halvorsen B; Aukrust P; Bjørås M
Cell Rep; 2020 Mar; 30(12):4165-4178.e7. PubMed ID: 32209476
[TBL] [Abstract][Full Text] [Related]
34. Mediator complex recruits epigenetic regulators via its two cyclin-dependent kinase subunits to repress transcription of immune response genes.
Tsutsui T; Fukasawa R; Shinmyouzu K; Nakagawa R; Tobe K; Tanaka A; Ohkuma Y
J Biol Chem; 2013 Jul; 288(29):20955-20965. PubMed ID: 23749998
[TBL] [Abstract][Full Text] [Related]
35. Determinants of histone H4 N-terminal domain function during nucleosomal array oligomerization: roles of amino acid sequence, domain length, and charge density.
McBryant SJ; Klonoski J; Sorensen TC; Norskog SS; Williams S; Resch MG; Toombs JA; Hobdey SE; Hansen JC
J Biol Chem; 2009 Jun; 284(25):16716-16722. PubMed ID: 19395382
[TBL] [Abstract][Full Text] [Related]
36. Interaction assessments of the first S-adenosylmethionine competitive inhibitor and the essential interacting partner methylosome protein 50 with protein arginine methyltransferase 5 by combined computational methods.
Zhu K; Jiang CS; Hu J; Liu X; Yan X; Tao H; Luo C; Zhang H
Biochem Biophys Res Commun; 2018 Jan; 495(1):721-727. PubMed ID: 29154828
[TBL] [Abstract][Full Text] [Related]
37. Biochemical Investigation of the Interaction of pICln, RioK1 and COPR5 with the PRMT5-MEP50 Complex.
Krzyzanowski A; Gasper R; Adihou H; Hart P'; Waldmann H
Chembiochem; 2021 Jun; 22(11):1908-1914. PubMed ID: 33624332
[TBL] [Abstract][Full Text] [Related]
38. Methylosome protein 50 promotes androgen- and estrogen-independent tumorigenesis.
Wei TY; Hsia JY; Chiu SC; Su LJ; Juan CC; Lee YC; Chen JM; Chou HY; Huang JY; Huang HM; Yu CT
Cell Signal; 2014 Dec; 26(12):2940-50. PubMed ID: 25277535
[TBL] [Abstract][Full Text] [Related]
39. Yeast Hmt1 catalyses asymmetric dimethylation of histone H3 arginine 2 in vitro.
Li HT; Gong T; Zhou Z; Liu YT; Cao X; He Y; Chen CD; Zhou JQ
Biochem J; 2015 May; 467(3):507-15. PubMed ID: 25715670
[TBL] [Abstract][Full Text] [Related]
40. Effects of substrate modifications on the arginine dimethylation activities of PRMT1 and PRMT5.
Fulton MD; Dang T; Brown T; Zheng YG
Epigenetics; 2022 Jan; 17(1):1-18. PubMed ID: 33380261
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
